← Browse by Condition
Medical Condition
central serous chorioretinopathy
Total Trials
3
Recruiting Now
3
Trial Phases
Various
ClinicalMetric tracks all active clinical trials for central serous chorioretinopathy sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Top Sponsors
1 trial
1 trial
1 trial
NCT05589974
Recruiting
Choroidal Blood Flow in Acute and Chronic Central Serous Chorioretinopathy
Enrollment
50 pts
Location
Norway
Sponsor
Helse Stavanger HF
NCT05570591
Recruiting
Subthreshold Nanosecond Laser for Non-resolving Central Serous Chorioretinopathy
Enrollment
60 pts
Location
Australia
Sponsor
Nova Eye Medical Pty Ltd.
NCT02141308
Recruiting
OCT in Rare Chorioretinal Diseases
Enrollment
150 pts
Location
United States
Sponsor
Oregon Health and Science Univ...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology